SCHEMBL4862318

SCHEMBL4862318

Cc1ccc(N=C(N)c2ccccc2)cc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.60
MEN1 O00255 1/20 0.60
CYP2D6 P10635 2/20 0.56
HIF1A Q16665 1/20 0.56
QRFPR Q96P65 5/20 0.47
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 1/20 0.41
GFER P55789 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NOS1 P29475 3/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11769944 0.98 KMT2A (0.58) KMT2AMEN1CYP2D6HIF1AQRFPR
SCHEMBL4855919 0.81 QRFPR (0.48) KMT2AMEN1QRFPRRAB9ANPC1
SCHEMBL4858649 0.80 NOS3 (0.50) KMT2AMEN1CYP2D6HIF1AQRFPR
SCHEMBL4853050 0.79 CYP2D6 (0.85) KMT2AMEN1CYP2D6HIF1AQRFPR
SCHEMBL11789365 0.79 CYP2D6 (0.85) KMT2AMEN1CYP2D6HIF1AQRFPR
Hydrochloric Acid SCHEMBL11769269 0.78 CYP2D6 (0.82) KMT2AMEN1CYP2D6HIF1AQRFPR
Hydrochloric Acid SCHEMBL11769271 0.78 CYP2D6 (0.82) KMT2AMEN1CYP2D6HIF1AQRFPR
SCHEMBL4853087 0.78 GRIN2B (0.46) KMT2AMEN1CYP2D6HIF1ALMNA
SCHEMBL4409091 0.77 HTR3E (0.58) CYP2D6CYP2C19TDP1HTR3EHTR3B
Hydrochloric Acid SCHEMBL11770106 0.76 CYP2D6 (0.62) KMT2AMEN1CYP2D6HIF1AQRFPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP KMT2A 4298/4885MEN1 917/4885CYP2D6 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.